Palvella Therapeutics (PVLA) Live Share Price, Invest From India

Palvella Therapeutics Stock Performance

as on August 19, 2026 at 3:09 am IST

Day's Low
Day's High
$149.08
Day's Price Range
$154.56
$151.96
1.90%
Downside
1.71%
Upside
52 Week's Low
52 Week's High
$46.08
52-Week Price Range
$161.38
$151.96
69.68%
Downside
6.20%
Upside

Palvella Therapeutics share price movements today

Previous Close: $153.52
Open: $152.99
Volume: 48.7K
Market Cap: $2.2B
Day's Low - High: $149.08 - $154.56
52 Week Low - High: $46.08 - $161.38

Palvella Therapeutics Historical Returns

1 Month Return: -0.71 %
3 Month Return: + 36.67 %
1 Year Return: + 230.08 %
3 Year Return: 0 %
5 Year Return: 0 %

Palvella Therapeutics Stock Fundamentals & Key Indicators

Check Palvella Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.2B

EPS (TTM)

-6.3708

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-46.63%

Palvella Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Palvella Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Palvella Therapeutics	StrongBuy	$2.2B	NA	NA	0.00%	NA
Revolution Medicines	BUY	$43.7B	669.3%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$128.2B	154.86%	29.82	86.04%	NA
Regeneron	BUY	$82.7B	24.1%	19.24	84.86%	0.44999999999999996%

Stock Returns calculator for Palvella Therapeutics Stock including INR - Dollar returns

The Palvella Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Palvella Therapeutics investment value today

Current value as on today

₹3,52,026

Returns

₹2,52,026

(+252.03%)

Returns from Palvella Therapeutics Stock

₹2,21,268 (+221.27%)

Dollar Impact

₹30,758 (+30.76%)

Analyst Recommendation on Palvella Therapeutics Stock

Based on 11 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 11 analysts, 100% of analysts recommend a 'BUY' rating for Palvella Therapeutics. Average target price of $233.82

Indian Investors' Interest in Palvella Therapeutics Stock

Search interest for Palvella Therapeutics Stock has increased by 143% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 19, 2026 to August 18, 2026

Change:143% versus previous 30 day period

Palvella Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-1	-2	-5	-4	-7	-9	-10	-11	-14	-21
EBITDA	-1	-3	-1	-2	-6	-8	0	-10	-17	-21
Interest Expense	0	1	1	1	1	1	1	1	2	2
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-4	-6	-3	-8	-9	-11	-12	-15	-21
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-2	-4	-6	-3	-8	-9	-11	-12	-15	-21
Net Profit Margin	-4784.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Palvella Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	5	25	29	46	29	31	25	-	-	-
Gross Profit	-	-	-	-	29	29	23	-	-	-
Operating Income	-22	-14	-30	-27	-33	-51	-43	-11	-14	-38
EBITDA	-22	-16	-26	-24	-34	-43	-30	18	-13	-35
Interest Expense	-	-	-	-	-	-	-	-	4	5
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-22	-16	-27	-25	-37	-45	-33	18	-17	-41
Income Tax Expense	0	1	0	-	0	-	-1	-	-	-
Net Income	-22	-17	-26	-25	-37	-45	-33	18	-17	-41
Net Profit Margin	-391.00%	-69.82%	-91.93%	-55.03%	-126.97%	-145.58%	-128.47%	0.00%	0.00%	0.00%

Palvella Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-4	-6	-3	-8	-9	-11	-7	-15	-21
Operating Cash Flow	-1	-2	-5	-6	-5	-7	-4	-10	-12
Investing Cash Flow	-	-	-3	-	-	-	-	-55	-7
Financing Cash Flow	9	2	74	-1	0	0	0	214	1
Change in Cash	0	0	69	56	-5	-6	-5	148	-18

Palvella Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-45	-27	18	-17	-41
Operating Cash Flow	-7	-14	-13	-10	-25
Investing Cash Flow	0	-21	-	-	-
Financing Cash Flow	59	9	5	87	0
Change in Cash	47	-5	-31	76	-25

Mutual Funds that own Palvella Therapeutics Stock

Check out the Mutual Funds with significant holdings in Palvella Therapeutics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	3.228392%	465160
Federated Hermes Equity Funds	2.963936%	427056
MUTUAL FUND SERIES TRUST	1.606589%	231484
Fidelity Securities Fund	1.353515%	195020
Prudential Sector Funds, Inc.	1.270348%	183037

See all

Global Institutional Holdings in Palvella Therapeutics

Funds	Holdings
Vanguard	4.37%
SPDR	3.15%
iShares	2.88%
Michael Rockefeller	2.2%
Joseph Edelman	1.85%

See all

Insights on Palvella Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, PVLA stock has moved up by 46.1%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 271.8%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 37.4%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 20.05M → 53.0K (in $), with an average decrease of 64.0% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 7 quarters, -3.95M → -21.87M (in $), with an average decrease of 36.2% per quarter

About Palvella Therapeutics

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapamycin, a novel, 3.9% anhydrous topical gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of angiokeratomas and other mTOR-driven skin diseases; and QTORIN pitavastatin for the treatment of disseminated superficial actinic porokeratosis. The company is based in Wayne, Pennsylvania.

Organisation	Palvella Therapeutics
Headquarters	353 W. Lancaster Avenue, Wayne, PA, United States, 19087
Industry	Biotechnology
CEO	Mr. Wesley H. Kaupinen
E-voting on shares	Click here to vote

Key Management of Palvella Therapeutics

Name	Title
Ms. Bohan Wei	Vice President of Corporate Development & New Product Planning
Ms. Sarah Foster	Senior Vice President of Human Resources
Ms. Emily Cook	Senior Vice President of Clinical Operations
Mr. Jason Burdette	SVP of CMC & Technical Operations
Ms. Ashley Hartmann Kline M.B.A.	Chief Commercial Officer
Mr. Wesley H. Kaupinen	Founder, President, CEO & Director
Ms. Kathleen Goin	Chief Operating Officer
Dr. Jeffrey Martini Ph.D.	Chief Scientific Officer
Mr. Matthew E. Korenberg	CFO, Corporate Secretary & Treasurer
Mr. Kent Taylor	Senior Vice President of Sales

FAQs

What is Palvella Therapeutics share price today?

Palvella Therapeutics share price today is $151.96 as on August 18, 2026 at 9:39 pm IST. Palvella Therapeutics share today touched a day high of $154.56 and a low of $149.08.

What is the 52 week high and 52 week low for Palvella Therapeutics share?

Palvella Therapeutics share touched a 52 week high of $161.38 on June 30, 2026 and a 52 week low of $46.08 on August 20, 2025. Palvella Therapeutics stock price today i.e. August 18, 2026 at 9:39 pm IST is trending at $151.96,which is 5.84% down from its 52 week high and 229.77% up from its 52 week low.

What is Palvella Therapeutics's market capitalisation today?

Palvella Therapeutics market capitalisation is $0.00T as on August 18, 2026 at 9:39 pm IST.

How to invest in Palvella Therapeutics Stock (PVLA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Palvella Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Palvella Therapeutics Shares that will get you 0.0099 shares as per Palvella Therapeutics share price of $151.96 per share as on August 18, 2026 at 9:39 pm IST.

What is the minimum amount required to buy Palvella Therapeutics Stock (PVLA) from India?

Indian investors can start investing in Palvella Therapeutics (PVLA) shares with as little as ₹95.67 or $1 (as of August 18, 2026 at 9:45 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in Palvella Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 18, 2026 at 9:45 pm IST). Based on Palvella Therapeutics share’s latest price of $151.96 as on August 18, 2026 at 9:39 pm IST, you will get 0.0658 shares of Palvella Therapeutics. Learn more about fractional shares .